SIBN:NASDAQ, SI-BONE, Inc.
SIBN stock overview
SI-BONE, Inc. (SIBN:NASDAQ) closed at $21.48 on October 23, 2026,
down 0.37% on the day.
The stock trades 1.9% below its 52-week high of $21.89
and 87.1% above its 52-week low of $11.48.
Over the past year, it gained 38.7%.
SI-BONE, Inc. is part of the Health Care sector (Medical/Dental Instruments).
Key figures
- Price
- $21.48
- Day change
- -0.37%
- Volume
- 469,087
- Average volume
- 566,718
- Market cap
- 962M+
- 52-week range
- $11.48 – $21.89
- 50-day average
- $19.12
- 200-day average
- $16.33
Price action over the past year
In 252 trading sessions since October 23, 2025, SIBN closed higher on 119 days (47%).
Its best day was May 12, 2026 (+19.72%) and its worst was January 12, 2026 (-12.57%).
The stock moved 10% or more in a single session 3 times.
Recent signals
SIBN news
-
Oct 19, 2026:
SI-BONE To Report Third Quarter 2026 Financial Results on November 2, 2026
-
Sep 28, 2026:
SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx, Extending Its Compromised Bone Franchise Beyond the Pelvis
-
Sep 28, 2026:
SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis
-
Aug 31, 2026:
SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026
-
Aug 25, 2026:
Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?
-
Aug 24, 2026:
Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 25.25%: Here's is How to Trade
-
Aug 11, 2026:
SI-BONE (SIBN) Q2 2026 Earnings Call Transcript
-
Aug 6, 2026:
Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?
About SI-BONE, Inc.
SI-BONE Inc is a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain.
Similar stocks
Find more stocks like SIBN with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.